Trends in hospitalizations among children and young adults with perinatally acquired HIV

Pediatric Infectious Disease Journal

Volumn 33, Issue 5, 2014, Pages 488-494

  Berry, Stephen A ^a   Gebo, Kelly A ^a   Rutstein, Richard M ^b   Althoff, Keri N ^c   Korthuis, P Todd ^d   Gaur, Aditya H ^e   Spector, Stephen A ^f   Warford, Robert ^g   Yehia, Baligh R ^h   Agwu, Allison L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AIDS defining illnesses; antiretroviral therapy; hospitalizations; perinatally HIV infected patients

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ADULT DISEASE; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEGRO; OUTCOME ASSESSMENT; OUTPATIENT CARE; PERINATALLY ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; THROMBOEMBOLISM; HIV INFECTIONS; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; NEWBORN; PRESCHOOL CHILD; TRENDS; VIROLOGY; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; YOUNG ADULT;

EID: 84899493911     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000126     Document Type: Article

References (41)

1. Buchacz K, Baker RK, Moorman AC, et al.; HIV Outpatient Study (HOPS) Investigators. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005. AIDS. 2008;22:1345-1354.
2. Berry SA, Fleishman JA, Moore RD, et al.; HIV Research Network. Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008. J Acquir Immune Defic Syndr. 2012;59:368-375.
3. Montaner J, Nosyk B, Colley G, et al. The Evolution of the Cascade of HIV Care: British Columbia, Canada, 1996-2010. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA. March 3, 2013.
4. Yehia BR, Fleishman JA, Metlay JP, et al. Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA. 2012;308: 339-342.
5. Agwu AL, Fleishman JA, Rutstein R, et al. Changes in advanced immunosuppression and detectable HIV viremia among perinatally HIV-infected youth in the multisite United States HIV Research Network. J Pediatric Infect Dis Soc. 2013:1-9.
6. Judd A, Doerholt K, Tookey PA, et al.; Collaborative HIV Paediatric Study (CHIPS); National Study of HIV in Pregnancy and Childhood (NSHPC). Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis. 2007;45:918-924.
7. Foster C, Judd A, Tookey P, et al.; Collaborative HIV Paediatric Study (CHIPS). Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. AIDS Patient Care STDS. 2009;23:159-166.
8. de Mulder M, Yebra G, Navas A, et al.; Madrid Cohort of HIV-Infected Children. High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain. PLoS One. 2012;7:e52155.
9. Van Dyke RB, Patel K, Siberry GK, et al.; Pediatric HIV/AIDS Cohort Study. Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr. 2011;57:165-173.
10. Blum RW, McNeely C, Nonnemaker J. Vulnerability, risk, and protection. J Adolesc Health. 2002;31(1 suppl):28-39.
11. Purswani M, Patel K, Kopp JB, et al.; Pediatric HIVAIDS Cohort Study. Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection. Pediatr Infect Dis J. 2013;32:495-500.
12. Pontrelli G, Cotugno N, Amodio D, et al. Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors. BMC Infect Dis. 2012;12:18.
13. Sims A, Frank L, Cross R, et al. Abnormal cardiac strain in children and young adults with HIV acquired in early life. J Am Soc Echocardiogr. 2012;25:741-748.
14. Lipshultz SE, Mas CM, Henkel JM, et al. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults. Expert Rev Anti Infect Ther. 2012;10:661-674.
15. Judd A, Boyd KL, Stöhr W, et al. Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. AIDS. 2010;24:525-534.
16. Moore RD. Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17(suppl 1):S38-S41.
17. Gebo KA, Diener-West M, Moore RD. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;27:143-152.
18. Elixhauser A, Steiner C, Palmer L. Clinical Classifications Software (CCS), 2012. U.S. Agency for Healthcare Research and Quality. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed January 27, 2014.
19. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep. 1994;43:1-24.
20. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1-19.
21. Free only searchable 2009 ICD-9-CM, 2013. Available at: http://www. icd9cm.chrisendres.com. Accessed June 13, 2013.
22. StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
23. Mofenson LM, Brady MT, Danner SP, et al.; Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009;58(RR-11):1-166.
24. Kourtis AP, Bansil P, Posner SF, et al. Trends in hospitalizations of HIV-infected children and adolescents in the United States: analysis of data from the 1994-2003 Nationwide Inpatient Sample. Pediatrics. 2007;120:e236-e243.
25. Viani RM, Araneta MR, Deville JG, et al. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2004;39:725-731.
26. Sánchez JM, Ramos Amador JT, Fernández de Miguel S, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2003;22:863-867.
27. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296:292-300.
28. Bertolli J, Hsu HW, Sukalac T, et al.; Pediatric Spectrum of HIV Disease Study. Hospitalization trends among children and youths with perinatal human immunodeficiency virus infection, 1990-2002. Pediatr Infect Dis J. 2006;25:628-633.
29. Resino S, Resino R, Maria Bellón J, et al.; Spanish Group of Pediatric HIV Infection. Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children. Clin Infect Dis. 2006;43:243-252.
30. U.S. Food and Drug Administration. Drugs@FDA: FDA approved drug products. 2013. Available at:http://www.accessdata.fda.gov/scripts/cder/drugsatfda/. Accessed June 12, 2013.
31. Funck-Brentano I, Dalban C, Veber F, et al. Evaluation of a peer support group therapy for HIV-infected adolescents. AIDS. 2005;19:1501-1508.
32. Parsons GN, Siberry GK, Parsons JK, et al. Multidisciplinary, inpatient directly observed therapy for HIV-1-infected children and adolescents failing HAART: A retrospective study. AIDS Patient Care STDS. 2006;20:275-284.
33. Berrien VM, Salazar JC, Reynolds E, et al.; HIV Medication Adherence Intervention Group. Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention. AIDS Patient Care STDS. 2004;18:355-363.
34. Dowshen N, Kuhns LM, Gray C, et al. Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth. AIDS Behav. 2013;17:2237-2243.
35. Shegog R, Markham CM, Leonard AD, et al. "+CLICK": pilot of a web-based training program to enhance ART adherence among HIV-positive youth. AIDS Care. 2012;24:310-318.
36. Centers for Disease Control and Prevention (CDC). National hospital discharge survey, 2010. http://www.cdc.gov/nchs/nhds/nhds-tables. htm#number. Accessed June 12, 2013.
37. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clin Infect Dis. 2007;44:599-604.
38. Kourtis AP, Paramsothy P, Posner SF, et al. National estimates of hospital use by children with HIV infection in the United States: analysis of data from the 2000 KIDS Inpatient Database. Pediatrics. 2006;118:e167-e173.
39. Pfunter A, Wier L, Stocks C. Most frequent conditions in U.S. hospitals, 2010. HCUP Statistical Brief #148. 2013. http://www.hcup-us.ahrq.gov/reports/ statbriefs/sb148.pdf. Accessed June 13, 2013.
40. Engsig FN, Hansen AB, Gerstoft J, et al. Inpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995-2007. AIDS. 2010;24:457-461.
41. Dollfus C, Le Chenadec J, Faye A, et al. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis. 2010;51: 214-224.